Drug recall · June 24, 2020
Olanzapine Tablets recall
Why: Failed Impurities/ Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Olanzapine Tablets, USP 7.5 mg, 30-count bottle, Rx only, Manufactured for: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Aurolife Pharma LLC Dayton, NJ 08810, NDC 66993-682-30
- Lots / codes
Lot #: 563180012A1, Exp 8/2020
- Quantity
- 7547 bottles
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- May 26, 2020 · Voluntary: Firm initiated
- Classified
- June 17, 2020
- Reported
- June 24, 2020
- Ended
- January 10, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olanzapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.